[Form 4] DocuSign, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 filing by Peter Solvik, a director at DocuSign (DOCU), reports receipt of equity awards and current beneficial ownership. The filing shows a grant of 729 restricted stock units (RSUs) on 08/29/2025 under transaction code M, with a reported acquisition price of $0. The RSUs convert one-for-one into common shares and are reflected as 729 underlying shares held directly following the transaction.

The filing also discloses other holdings: 6,783 shares directly, 150,253 shares held by a trust, 65,558 by children’s trusts, 3 by a family partnership, and 6,458 by spouse. The RSUs have a May 29, 2025 vest commencement date and vest quarterly over one year, with specific acceleration language for the fourth installment.

Positive

• Grant of 729 RSUs aligns director compensation with long-term shareholder value
• Transparent disclosure of direct and indirect beneficial ownership across trusts and family vehicles

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine director equity grant; modest incremental dilution and aligns director compensation with shareholder interests.

The transaction is a standard equity compensation grant of 729 RSUs to a director, reported under Rule 16. The award vests over one year in quarterly installments, with a clause accelerating the final installment to the next annual meeting or one-year anniversary. The direct addition of 729 shares is immaterial relative to DocuSign's outstanding share count but signals retention/incentive alignment. No cash was paid and no dispositions were reported. Overall, this is a routine governance/compensation disclosure with limited market impact.

Corporate Governance Expert

TL;DR: Standard governance practice—time-based RSUs issued to a director with customary vesting and no unusual terms disclosed.

The filing documents time-based RSUs that convert 1:1 to common stock and include customary vesting mechanics and an acceleration provision tied to the annual meeting or one-year anniversary. The report details multiple indirect ownership vehicles (trusts, spouse, family partnership), providing transparency on beneficial ownership. There are no indications of related-party sales, exercising of options, or other atypical arrangements. This disclosure meets Section 16 requirements and appears routine.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Solvik Peter

(Last) (First) (Middle)

C/O JACKSON SQUARE VENTURES

727 SANSOME STREET

(Street)

SAN FRANCISCO CA 94111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		M		729	A	$0	6,783	D
Common Stock								150,253	I	By Trust
Common Stock								65,558	I	By Children's Trusts
Common Stock								3	I	By Family Partnership
Common Stock								6,458	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/29/2025		M			729	(2)	(3)	Common Stock	729	$0	2,187	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date.

3. The RSUs do not expire; they either vest or are canceled prior to vesting date.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Peter Solvik report in his Form 4 for DOCU?

He reported a grant of 729 RSUs on 08/29/2025 and beneficial ownership totaling 229,055 shares across direct and indirect holdings (6,783 direct; 150,253 trust; 65,558 children's trusts; 3 family partnership; 6,458 spouse).

When do the RSUs granted to Peter Solvik vest?

The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment accelerating to the earlier of the next annual meeting or the one-year anniversary.

Did Peter Solvik pay anything to acquire the RSUs?

No. The reported acquisition price for the 729 RSUs is $0.

Are there any derivative or option transactions reported by Solvik in this filing?

Yes. The filing shows Restricted Stock Units as derivative securities converting to common stock, representing 729 underlying shares following the transaction.

Who signed the Form 4 on behalf of the reporting person and when?

The form was signed by Derrick Chapman, Attorney-in-fact on 09/02/2025.